# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA706858 | A | In vivo cytotoxicity of intraperitoneally administered compound at dose 1.6 mg/kg/inj was determined against ip implanted murine M-109 lung carcinoma | Mus musculus | 1 | organism-based format | Scientific Literature | ||
2. | ALA706859 | A | In vivo cytotoxicity of intraperitoneally administered compound at dose 16 mg/kg/inj was determined against ip implanted murine M-109 lung carcinoma | Mus musculus | 1 | organism-based format | Scientific Literature | ||
3. | ALA706860 | A | In vivo cytotoxicity of intraperitoneally administered compound at dose 1 mg/kg/injection was determined against ip implanted murine M-109 lung carcinoma | Mus musculus | 1 | organism-based format | Scientific Literature | ||
4. | ALA706861 | A | In vivo cytotoxicity of intraperitoneally administered compound at dose 25 mgkg/inj was determined against ip implanted murine M-109 lung carcinoma | Mus musculus | 1 | organism-based format | Scientific Literature | ||
5. | ALA708393 | A | In vivo cytotoxicity of intraperitoneally administered compound at dose 32 mg/kg/inj was determined against ip implanted murine M-109 lung carcinoma | Mus musculus | 1 | organism-based format | Scientific Literature | ||
6. | ALA708394 | A | In vivo cytotoxicity of intraperitoneally administered compound at dose 3 mg/kg/inj was determined against ip implanted murine M-109 lung carcinoma | Mus musculus | 1 | organism-based format | Scientific Literature | ||
7. | ALA708395 | A | In vivo cytotoxicity of intraperitoneally administered compound at dose 4 mg/kg/inj was determined against ip implanted murine M-109 lung carcinoma | Mus musculus | 2 | organism-based format | Scientific Literature | ||
8. | ALA708396 | A | In vivo cytotoxicity of intraperitoneally administered compound at dose 50 mgkg/inj was determined against ip implanted murine M-109 lung carcinoma | Mus musculus | 1 | organism-based format | Scientific Literature | ||
9. | ALA709010 | A | In vivo cytotoxicity of intraperitoneally administered compound at dose 60 mg/kg/inj was determined against ip implanted murine M-109 lung carcinoma; value ranges from 159-228 mg/Kg/inj | Mus musculus | 1 | organism-based format | Scientific Literature | ||
10. | ALA708472 | A | In vivo cytotoxicity of intraperitoneally administered compound at dose 6 mg/kg/inj was determined against ip implanted murine M-109 lung carcinoma | Mus musculus | 2 | organism-based format | Scientific Literature | ||
11. | ALA708473 | A | In vivo cytotoxicity of intraperitoneally administered compound was determined against ip implanted murine M-109 lung carcinoma; NA means not active | Mus musculus | 7 | organism-based format | Scientific Literature | ||
12. | ALA708474 | F | The compound was evaluated in vivo for the T/C ratio against M-109 lung carcinoma. | Mus musculus | 2 | organism-based format | Scientific Literature | ||
13. | ALA708475 | F | In vivo antitumor activity evaluated against M-109 murine lung carcinoma cells in BALB/c mice administered intraperitoneally at a dose of 10 mg/kg | Mus musculus | 1 | organism-based format | Scientific Literature | ||
14. | ALA708476 | F | In vivo antitumor activity evaluated against M-109 murine lung carcinoma cells in BALB/c mice administered intraperitoneally at a dose of 4.5 mg/kg | Mus musculus | 1 | organism-based format | Scientific Literature | ||
15. | ALA874169 | F | Inhibition of M109 mouse lung carcinoma cell proliferation | Mus musculus | 3 | cell-based format | Scientific Literature | ||
16. | ALA711328 | F | In vivo efficacy against Madison Murine lung carcinoma M109 tumors implanted ip and the drug given ip on days 5 and 8 post implantation | Mus musculus | 2 | organism-based format | Scientific Literature | ||
17. | ALA711329 | F | In vivo efficacy against Madison Murine lung carcinoma M109 tumors implanted ip and the drug given ip on days 5 and 8 post implantation. | Mus musculus | 19 | organism-based format | Scientific Literature | ||
18. | ALA711330 | F | In vivo efficacy against Madison Murine lung carcinoma M109 tumors implanted sc and the drug given iv every day x 5 beginning 4 days post implantation. | Mus musculus | 4 | organism-based format | Scientific Literature | ||
19. | ALA711331 | F | Tested for cytotoxicity in murine lung carcinoma (M109) | Mus musculus | 2 | cell-based format | Scientific Literature | ||
20. | ALA711332 | F | Tested for cytotoxicity in murine lung carcinoma (M109); not cytotoxic at the highest concentration tested (70 uM) | Mus musculus | 2 | cell-based format | Scientific Literature |